Your Article Summary
See Latest ArticlesSacroiliitis and severe disability due to isotretinoin therapy
Rheumatology International, 06/23/09
Rozin AP et al. - The authors report a case of acute sacroiliitis with severe disability after only 3 weeks of isotretinoin therapy with graduate reduction of pain, limitation and muscle incompetence after discontinuation of the drug and ACTH-depo injection and Ethodolac therapy. Naranjo probability scale indicated a probable relationship between isotretinoin therapy and bilateral sacroiliitis.
Related Articles
Clinical utility of ultrasonography in spondyloarthropathies
Current Rheumatology Reports, 10/14/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis
Rheumatology International, 12/15/09
First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09
Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population
Rheumatology International, 12/15/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09
Fetuin-A and interleukin-18 levels in ankylosing spondylitis
International Journal of Rheumatic Diseases, 12/15/09